Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients

Tight glycaemic control in critically ill patients is used to reduce mortality in intensive care units. However, its usage is debatable in reducing hypoglycaemia or accurately maintain normoglycaemia level. This paper presents the assessment for two 'wider' Stochastic TARgeted (STAR) glyce...

Full description

Saved in:
Bibliographic Details
Main Authors: Razak A.A., Abu-Samah A., Razak N.N., Baharudin S., Suhaimi F., Jamaludin U., Ralib A., Mat-Nor M.B.
Other Authors: 56960052400
Format: Article
Published: Science Publishing Corporation Inc 2023
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Tenaga Nasional
id my.uniten.dspace-24119
record_format dspace
spelling my.uniten.dspace-241192023-05-29T14:55:42Z Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients Razak A.A. Abu-Samah A. Razak N.N. Baharudin S. Suhaimi F. Jamaludin U. Ralib A. Mat-Nor M.B. 56960052400 56719596600 37059587300 55180778800 36247893200 55330889600 37031770900 57226799207 Tight glycaemic control in critically ill patients is used to reduce mortality in intensive care units. However, its usage is debatable in reducing hypoglycaemia or accurately maintain normoglycaemia level. This paper presents the assessment for two 'wider' Stochastic TARgeted (STAR) glycemic controllers, namely Controller A (blood glucose (BG) target 4.4-8.0 mmol/L) and Controller B (BG target 4.4-10.0 mmol/L) with 1 to 3 hour nursing interventions. These controllers were assessed to determine the better control on diabetic and non-diabetic patients. 66 diabetic and 66 non-diabetic critically ill patient's data from Hospital Tunku Ampuan Afzan (HTAA) were employed for virtual trial simulations with a clinically validated physiological model. Performance metrics were assessed within the percentage time in band (TIB) of 4.4 to 8.0 mmol/L, 4.4 to 10.0 mmol/L, and 6.0 to 10.0 mmol/L. Controller A shows better performance in normoglycaemic TIB of 4.4 to 10.0 mmol/L where non-diabetic and diabetic patients achieved 92.5% and 83.8% respectively. In conclusion, Controller A is higher in efficiency and safer to be used for both patients cohorts. However, higher clinical interventions in diabetic patients within this control raise the alarm to reduce nursing workload. This is believed to improve clinical interventions burnout and ensure patient's comfortability. � 2018 Authors. Final 2023-05-29T06:55:42Z 2023-05-29T06:55:42Z 2018 Article 10.14419/ijet.v7i4.35.22322 2-s2.0-85059224763 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059224763&doi=10.14419%2fijet.v7i4.35.22322&partnerID=40&md5=a0349415517ed068eff5dd685bb5c3df https://irepository.uniten.edu.my/handle/123456789/24119 7 4 54 58 All Open Access, Bronze, Green Science Publishing Corporation Inc Scopus
institution Universiti Tenaga Nasional
building UNITEN Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Tenaga Nasional
content_source UNITEN Institutional Repository
url_provider http://dspace.uniten.edu.my/
description Tight glycaemic control in critically ill patients is used to reduce mortality in intensive care units. However, its usage is debatable in reducing hypoglycaemia or accurately maintain normoglycaemia level. This paper presents the assessment for two 'wider' Stochastic TARgeted (STAR) glycemic controllers, namely Controller A (blood glucose (BG) target 4.4-8.0 mmol/L) and Controller B (BG target 4.4-10.0 mmol/L) with 1 to 3 hour nursing interventions. These controllers were assessed to determine the better control on diabetic and non-diabetic patients. 66 diabetic and 66 non-diabetic critically ill patient's data from Hospital Tunku Ampuan Afzan (HTAA) were employed for virtual trial simulations with a clinically validated physiological model. Performance metrics were assessed within the percentage time in band (TIB) of 4.4 to 8.0 mmol/L, 4.4 to 10.0 mmol/L, and 6.0 to 10.0 mmol/L. Controller A shows better performance in normoglycaemic TIB of 4.4 to 10.0 mmol/L where non-diabetic and diabetic patients achieved 92.5% and 83.8% respectively. In conclusion, Controller A is higher in efficiency and safer to be used for both patients cohorts. However, higher clinical interventions in diabetic patients within this control raise the alarm to reduce nursing workload. This is believed to improve clinical interventions burnout and ensure patient's comfortability. � 2018 Authors.
author2 56960052400
author_facet 56960052400
Razak A.A.
Abu-Samah A.
Razak N.N.
Baharudin S.
Suhaimi F.
Jamaludin U.
Ralib A.
Mat-Nor M.B.
format Article
author Razak A.A.
Abu-Samah A.
Razak N.N.
Baharudin S.
Suhaimi F.
Jamaludin U.
Ralib A.
Mat-Nor M.B.
spellingShingle Razak A.A.
Abu-Samah A.
Razak N.N.
Baharudin S.
Suhaimi F.
Jamaludin U.
Ralib A.
Mat-Nor M.B.
Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
author_sort Razak A.A.
title Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
title_short Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
title_full Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
title_fullStr Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
title_full_unstemmed Virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
title_sort virtual trial of glycaemic control performance and nursing workload assessment in diabetic critically ill patients
publisher Science Publishing Corporation Inc
publishDate 2023
_version_ 1806428293907349504